
Published
Bispecific Antibody Design for Cancer Immunotherapy
Computational design of a bispecific DuoBody antibody targeting 4-1BB and PD-L1 for non-small cell lung cancer, published at IEEE ISEC 2025.
cancer immunotherapybispecific antibodiescomputational biology
- Outcome
- Docking and molecular dynamics confirmed an optimal bispecific antibody design for 4-1BB and PD-L1. The selected design showed high predicted affinity and stability, supporting it as a promising NSCLC-targeting candidate. Published at IEEE ISEC 2025 and recognized with the Outstanding Poster Presentation Award (ACS NERD 2025) and the Medal of High Honors (Terra Science Fair).
- Method
- 1.Protein selection
- 2.Structure modeling
- 3.Binding-site identification
- 4.Molecular docking
- 5.Interaction analysis
- 6.Molecular dynamics
- Tools
- AlphaFoldGROMACSHDockPLIPProdigyBiopythonStreamlit